Free Access
Med Sci (Paris)
Volume 29, Number 1, Janvier 2013
Page(s) 47 - 55
Section M/S Revues
Published online 25 January 2013
  1. Knobel DL, Cleaveland S, Coleman PG, et al. Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 2005 ; 83 : 360–368. [PubMed] [Google Scholar]
  2. Davis PL, Bourhy H, Holmes EC. The evolutionary history and dynamics of bat rabies virus. Infect Genet Evol 2006 ; 6 : 464–473. [CrossRef] [PubMed] [Google Scholar]
  3. Dacheux L, Larrous F, Mailles A, et al. European bat Lyssavirus transmission among cats, Europe. Emerg Infect Dis 2009 ; 15 : 280–284. [CrossRef] [PubMed] [Google Scholar]
  4. Kuzmin IV, Shi M, Orciari LA, et al. Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001–2009. PLoS Pathog 2012 ; 8 : e1002786. [CrossRef] [PubMed] [Google Scholar]
  5. Leslie MJ, Messenger S, Rohde RE, et al. Bat-associated rabies virus in skunks. Emerg Infect Dis 2006 ; 12 : 1274–1277. [CrossRef] [PubMed] [Google Scholar]
  6. De Benedictis P, Gallo T, Iob A, et al. Emergence of fox rabies in north-eastern Italy. Euro Surveill 2008 ; 13 : 19033. [PubMed] [Google Scholar]
  7. Lardon Z, Watier L, Brunet A, et al. Imported episodic rabies increases patient demand for, physician delivery of antirabies prophylaxis. PLoS Negl Trop Dis 2010 ; 4 : e723. [CrossRef] [PubMed] [Google Scholar]
  8. Meynard JB, Flamand C, Dupuy C, et al. First human rabies case in French Guiana, 2008: epidemiological investigation and control. PLoS Negl Trop Dis 2012 ; 6 : e1537. [CrossRef] [PubMed] [Google Scholar]
  9. Bourhy H, Cowley JA, Larrous F, et al. Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J Gen Virol 2005 ; 86 : 2849–2858. [CrossRef] [PubMed] [Google Scholar]
  10. Holmes EC, Woelk CH, Kassis R, Bourhy H. Genetic constraints and the adaptive evolution of rabies virus in nature. Virology 2002 ; 292 : 247–257. [CrossRef] [PubMed] [Google Scholar]
  11. Prehaud C, Wolff N, Terrien E, et al. Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Sci Signal 2010 ; 3 : ra5. [CrossRef] [PubMed] [Google Scholar]
  12. Tuffereau C, Leblois H, Bénéjean J, et al. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 1989 ; 172 : 206–212. [CrossRef] [PubMed] [Google Scholar]
  13. Schumacher CL, Coulon P, Lafay F, et al. SAG-2 oral rabies vaccine. Onderstepoort J Vet Res 1993 ; 60 : 459–462. [PubMed] [Google Scholar]
  14. Larrous F, Gholami A, Mouhamad S, et al. Two overlapping domains of a lyssavirus matrix protein that acts on different cell death pathways. J Virol 2010 ; 84 : 9897–9906. [CrossRef] [PubMed] [Google Scholar]
  15. Vidy A, El Bougrini J, Chelbi-Alix MK, Blondel D. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 2007 ; 81 : 4255–4263. [CrossRef] [PubMed] [Google Scholar]
  16. Assenberg R, Delmas O, Morin B, et al. Genomics and structure/function studies of Rhabdoviridae proteins involved in replication and transcription. Antiviral Res 2010 ; 87 : 149–161. [CrossRef] [PubMed] [Google Scholar]
  17. Crepin P, Audry L, Rotivel Y, et al. Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid. J Clin Microbiol 1998 ; 36 : 1117–1121. [PubMed] [Google Scholar]
  18. Dacheux L, Reynes JM, Buchy P, et al. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 2008 ; 47 : 1410–1417. [Google Scholar]
  19. Maier T, Schwarting A, Mauer D, et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010 ; 50 : 1112–1119. [CrossRef] [PubMed] [Google Scholar]
  20. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005 ; 352 : 1103–1111. [CrossRef] [PubMed] [Google Scholar]
  21. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002 ; 1 : 101–109. [CrossRef] [PubMed] [Google Scholar]
  22. Hemachudha T, Wacharapluesadee S, Mitrabhakdi E, et al. Pathophysiology of human paralytic rabies. J Neurovirol 2005 ; 11 : 93–100. [CrossRef] [PubMed] [Google Scholar]
  23. Hemachudha T, Wacharapluesadee S, Laothamatas J, Wilde H. Rabies. Curr Neurol Neurosci Rep 2006 ; 6 : 460–468. [CrossRef] [PubMed] [Google Scholar]
  24. Jackson AC. Rabies: new insights into pathogenesis and treatment. Curr Opin Neurol 2006 ; 19 : 267–270. [CrossRef] [PubMed] [Google Scholar]
  25. WHO. Rabies vaccines: position paper. Wkl Epidemiol Rec 2010 ; 32 : 309–320. [Google Scholar]
  26. Quiambao BP, Dytioco HZ, Dizon RM, et al. Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab’)(2) fragment rabies immunoglobulin (Favirab). PLoS Negl Trop Dis 2008 ; 2 : e243. [CrossRef] [PubMed] [Google Scholar]
  27. Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 2010 ; 59 : 1–9. [Google Scholar]
  28. Dacheux L, Delmas O, Bourhy H. Human rabies encephalitis prevention and treatment: progress since Pasteur’s discovery. Infect Disord Drug Targets 2011 ; 11 : 251–299. [CrossRef] [PubMed] [Google Scholar]
  29. Willoughby RE, Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005 ; 352 : 2508–2514. [CrossRef] [PubMed] [Google Scholar]
  30. Willoughby RE Jr., A cure for a rabies? Sci Am 2007 ; 296 (4) : 88–95. [CrossRef] [PubMed] [Google Scholar]
  31. Gautret P, Shaw M, Gazin P, et al. Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study. J Travel Med 2008 ; 15 : 25–30. [CrossRef] [PubMed] [Google Scholar]
  32. Dodet B. The fight against rabies in Africa: From recognition to action. Vaccine 2009 27 : 5027–5032. [CrossRef] [PubMed] [Google Scholar]
  33. Bakker AB, Python C, Kissling CJ, et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine 2008 ; 26 : 5922–5927. [CrossRef] [PubMed] [Google Scholar]
  34. Both L, Banyard AC, van Dolleweerd C, et al. Passive immunity in the prevention of rabies. Lancet Infect Dis 2012 ; 12 : 397–407. [CrossRef] [PubMed] [Google Scholar]
  35. Dreyfus C. Vers un vaccin universel contre la grippe ? Med Sci (Paris) 2013 ; 29 : 22–25. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.